CNOT4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.917600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.388400E-01
Normal-vs-Stage2
3.456400E-01
Normal-vs-Stage3
1.868020E-02
Normal-vs-Stage4
9.803400E-01
Stage1-vs-Stage2
1.543400E-01
Stage1-vs-Stage3
6.519100E-03
Stage1-vs-Stage4
9.884600E-01
Stage2-vs-Stage3
5.295600E-02
Stage2-vs-Stage4
5.771000E-01
Stage3-vs-Stage4
1.536840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.672800E-01
Normal-vs-AfricanAmerican
8.229400E-01
Normal-vs-Asian
2.773600E-01
Caucasian-vs-AfricanAmerican
4.052600E-01
Caucasian-vs-Asian
4.803000E-01
AfricanAmerican-vs-Asian
3.238800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.616200E-01
Normal-vs-Female
4.361800E-01
Male-vs-Female
7.542600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.135200E-01
Normal-vs-Age(41-60Yrs)
7.798200E-01
Normal-vs-Age(61-80Yrs)
2.718000E-01
Normal-vs-Age(81-100Yrs)
7.084100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.869800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.350000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.151370E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.357800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.785930E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.495400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.293980E-01
Normal-vs-Daily Drinker
1.364430E-01
Normal-vs-Weekly Drinker
5.163000E-01
Normal-vs-Occasional Drinker
4.569000E-01
Normal-vs-Social Drinker
9.938000E-01
Non Drinker-vs-Daily Drinker
9.536600E-01
Non Drinker-vs-Weekly Drinker
1.484980E-01
Non Drinker-vs-Occasional Drinker
1.000200E-01
Non Drinker-vs-Social Drinker
9.422300E-03
Daily Drinker-vs-Weekly Drinker
1.819990E-01
Daily Drinker-vs-Occasional Drinker
1.281800E-01
Daily Drinker-vs-Social Drinker
1.603590E-02
Weekly Drinker-vs-Occasional Drinker
9.957600E-01
Weekly Drinker-vs-Social Drinker
3.150400E-01
Occasional Drinker-vs-Social Drinker
2.547000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.928180E-01
Normal-vs-Grade 2
5.722800E-01
Normal-vs-Grade 3
5.676800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.296400E-01
Grade 1-vs-Grade 3
9.975000E-01
Grade 1-vs-Grade 4
1.928180E-01
Grade 2-vs-Grade 3
8.994600E-01
Grade 2-vs-Grade 4
5.722800E-01
Grade 3-vs-Grade 4
5.676800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.178200E-01
Normal-vs-NonDiabetic
3.239400E-01
Diabetic-vs-NonDiabetic
3.296200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.559800E-01
Normal-vs-NoPancreatitis
2.996000E-01
Pancreatitis-vs-NoPancreatitis
5.704800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.572800E-01
Normal-vs-N1
3.613000E-01
N0-vs-N1
8.564000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.945400E-01
Normal-vs-TP53-NonMutant
7.072800E-01
TP53-Mutant-vs-TP53-NonMutant
2.523600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
